Apoptosis-dependent acute pulmonary injury after intratracheal instillation of angiotensin II.
To test the hypothesis that exogenous purified angiotensin II (ANG) might cause apoptosis of alveolar epithelial cells (AECs) and acute lung injury, male Wistar rats were intratracheally instilled with purified ANG (10 mumol/L), ANG plus the caspase inhibitor ZVAD-fmk (60 mumol/L), ANG plus the ANG receptor AT1 antagonist losartan (LOS, 100 mumol/L) or sterile phosphate-buffered saline (PBS) vehicle alone. Six or 20 h later, the lungs were lavaged in situ for determination of bronchoalveolar lavage (BAL) fluid content of hemoglobin (Hb) and fluorescent (BODIPY)-albumin, a bolus of which was injected intravenously 15 min prior to BAL. Terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) revealed that instillation of ANG, but not PBS alone, increased labeling of fragmented DNA in bronchiolar epithelial cells and in AECs (P<0.05) at 6 h post-ANG. Increased TUNEL was abrogated by concurrent instillation of ZVAD-fmk or LOS. Significant increased numbers of caspase-positive cells were observed by anti-caspase 3 immunolabeling after instillation of ANG (P<0.01); the same doses of LOS or ZVAD-fmk that blocked TUNEL also blocked the activation of caspase 3 (P<0.01). Intratracheal instillation of ANG also remarkably increased BAL BODIPY-albumin (P< 0.01) and Hb (P<0.05), both of which were eliminated by ZVAD-fmk or LOS. These data indicate that exposure of AECs to ANG in vivo is sufficient to induce apoptosis and alveolar epithelial barrier injury mediated by ANG receptor AT1.
Zhuang
Jia-Ju
JJ
Department of Physiology, Bethune Military Medical College, Shijiazhuang, China. zhuangjj@yahoo.com
Li
Xiao-Peng
XP
Uhal
Bruce David
BD
Yian
Koh Rhun
KR
D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D000804:Angiotensin II / Q000009:adverse effects*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000818:Animals; D017209:Apoptosis; D053148:Caspase 3 / Q000378:metabolism; D061945:Caspase Inhibitors / Q000494:pharmacology; D004847:Epithelial Cells / Q000473:pathology; D019808:Losartan / Q000494:pharmacology; D055370:Lung Injury / Q000139:chemically induced / Q000473:pathology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*
D000590:Amino Acid Chloromethyl Ketones; D047228:Angiotensin II Type 1 Receptor Blockers; D061945:Caspase Inhibitors; D044140:Receptor, Angiotensin, Type 1; C096713:benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone; D000804:Angiotensin II; C505410:Casp3 protein, rat; D053148:Caspase 3; D019808:Losartan